- Home
- CLLS vs MMD Comparison
CLLS vs MMD Comparison
Compare CLLS & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- MMD
- Stock Information
- Founded
- CLLS 1999
- MMD 2012
- Country
- CLLS France
- MMD United States
- Employees
- CLLS N/A
- MMD N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- MMD Investment Managers
- Sector
- CLLS Health Care
- MMD Finance
- Exchange
- CLLS Nasdaq
- MMD Nasdaq
- Market Cap
- CLLS 299.0M
- MMD 274.9M
- IPO Year
- CLLS 2007
- MMD N/A
- Fundamental
- Price
- CLLS $2.85
- MMD $14.55
- Analyst Decision
- CLLS Buy
- MMD
- Analyst Count
- CLLS 1
- MMD 0
- Target Price
- CLLS $4.00
- MMD N/A
- AVG Volume (30 Days)
- CLLS 199.3K
- MMD 74.7K
- Earning Date
- CLLS 08-04-2025
- MMD 01-01-0001
- Dividend Yield
- CLLS N/A
- MMD 4.88%
- EPS Growth
- CLLS N/A
- MMD N/A
- EPS
- CLLS N/A
- MMD N/A
- Revenue
- CLLS $63,438,000.00
- MMD N/A
- Revenue This Year
- CLLS N/A
- MMD N/A
- Revenue Next Year
- CLLS $4.90
- MMD N/A
- P/E Ratio
- CLLS N/A
- MMD N/A
- Revenue Growth
- CLLS 223.09
- MMD N/A
- 52 Week Low
- CLLS $1.10
- MMD $14.30
- 52 Week High
- CLLS $3.24
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- CLLS 59.27
- MMD 44.12
- Support Level
- CLLS $2.71
- MMD $14.40
- Resistance Level
- CLLS $3.08
- MMD $14.62
- Average True Range (ATR)
- CLLS 0.20
- MMD 0.26
- MACD
- CLLS -0.03
- MMD -0.02
- Stochastic Oscillator
- CLLS 61.67
- MMD 12.50
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.